Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

MHC I Expression Regulates Co-clustering and Mobility of Interleukin-2 and -15 Receptors in T Cells.

Mocsár G, Volkó J, Rönnlund D, Widengren J, Nagy P, Szöllősi J, Tóth K, Goldman CK, Damjanovich S, Waldmann TA, Bodnár A, Vámosi G.

Biophys J. 2016 Jul 12;111(1):100-12. doi: 10.1016/j.bpj.2016.05.044.

2.

90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.

Janik JE, Morris JC, O'Mahony D, Pittaluga S, Jaffe ES, Redon CE, Bonner WM, Brechbiel MW, Paik CH, Whatley M, Chen C, Lee JH, Fleisher TA, Brown M, White JD, Stewart DM, Fioravanti S, Lee CC, Goldman CK, Bryant BR, Junghans RP, Carrasquillo JA, Worthy T, Corcoran E, Conlon KC, Waldmann TA.

Proc Natl Acad Sci U S A. 2015 Oct 20;112(42):13045-50. doi: 10.1073/pnas.1516107112. Epub 2015 Oct 5.

3.

Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.

Nakagawa M, Schmitz R, Xiao W, Goldman CK, Xu W, Yang Y, Yu X, Waldmann TA, Staudt LM.

J Exp Med. 2014 Dec 15;211(13):2497-505. doi: 10.1084/jem.20140987. Epub 2014 Dec 8.

4.

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Conlon KC, Lugli E, Welles HC, Rosenberg SA, Fojo AT, Morris JC, Fleisher TA, Dubois SP, Perera LP, Stewart DM, Goldman CK, Bryant BR, Decker JM, Chen J, Worthy TA, Figg WD Sr, Peer CJ, Sneller MC, Lane HC, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA.

J Clin Oncol. 2015 Jan 1;33(1):74-82. doi: 10.1200/JCO.2014.57.3329. Epub 2014 Nov 17.

5.

Distinct spatial relationship of the interleukin-9 receptor with interleukin-2 receptor and major histocompatibility complex glycoproteins in human T lymphoma cells.

Nizsalóczki E, Csomós I, Nagy P, Fazekas Z, Goldman CK, Waldmann TA, Damjanovich S, Vámosi G, Mátyus L, Bodnár A.

Chemphyschem. 2014 Dec 15;15(18):3969-78. doi: 10.1002/cphc.201402501. Epub 2014 Oct 8.

6.

Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.

Berkowitz JL, Janik JE, Stewart DM, Jaffe ES, Stetler-Stevenson M, Shih JH, Fleisher TA, Turner M, Urquhart NE, Wharfe GH, Figg WD, Peer CJ, Goldman CK, Waldmann TA, Morris JC.

Clin Immunol. 2014 Dec;155(2):176-87. doi: 10.1016/j.clim.2014.09.012. Epub 2014 Sep 28.

7.
8.

Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia.

Waldmann TA, Conlon KC, Stewart DM, Worthy TA, Janik JE, Fleisher TA, Albert PS, Figg WD, Spencer SD, Raffeld M, Decker JR, Goldman CK, Bryant BR, Petrus MN, Creekmore SP, Morris JC.

Blood. 2013 Jan 17;121(3):476-84. doi: 10.1182/blood-2012-08-450585. Epub 2012 Dec 3.

9.

Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease.

Stahls PF 3rd, Lightell DJ Jr, Moss SC, Goldman CK, Woods TC.

J Cardiovasc Transl Res. 2013 Apr;6(2):232-8. doi: 10.1007/s12265-012-9429-9. Epub 2012 Dec 4.

10.

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques.

Waldmann TA, Lugli E, Roederer M, Perera LP, Smedley JV, Macallister RP, Goldman CK, Bryant BR, Decker JM, Fleisher TA, Lane HC, Sneller MC, Kurlander RJ, Kleiner DE, Pletcher JM, Figg WD, Yovandich JL, Creekmore SP.

Blood. 2011 May 5;117(18):4787-95. doi: 10.1182/blood-2010-10-311456. Epub 2011 Mar 8.

11.

Autocrine/paracrine cytokine stimulation of leukemic cell proliferation in smoldering and chronic adult T-cell leukemia.

Chen J, Petrus M, Bryant BR, Nguyen VP, Goldman CK, Bamford R, Morris JC, Janik JE, Waldmann TA.

Blood. 2010 Dec 23;116(26):5948-56. doi: 10.1182/blood-2010-04-277418. Epub 2010 Sep 21.

12.

Transient and persistent effects of IL-15 on lymphocyte homeostasis in nonhuman primates.

Lugli E, Goldman CK, Perera LP, Smedley J, Pung R, Yovandich JL, Creekmore SP, Waldmann TA, Roederer M.

Blood. 2010 Oct 28;116(17):3238-48. doi: 10.1182/blood-2010-03-275438. Epub 2010 Jul 14.

13.

Preclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma.

Zhang M, Yao Z, Garmestani K, Yu S, Goldman CK, Paik CH, Brechbiel MW, Carrasquillo JA, Waldmann TA.

Cancer Biother Radiopharm. 2009 Jun;24(3):303-9. doi: 10.1089/cbr.2008.0577.

14.

Hormone therapy for treatment of colonic vascular ectasia in 2 dogs.

Goldman CK, Parnell NK, Holland CH.

J Vet Intern Med. 2008 Jul-Aug;22(4):1048-51. doi: 10.1111/j.1939-1676.2008.0139.x. No abstract available.

15.

Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism.

Chen J, Petrus M, Bryant BR, Phuc Nguyen V, Stamer M, Goldman CK, Bamford R, Morris JC, Janik JE, Waldmann TA.

Blood. 2008 May 15;111(10):5163-72. doi: 10.1182/blood-2007-09-113654. Epub 2008 Mar 13.

16.

Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1.

Zhang M, Yao Z, Patel H, Garmestani K, Zhang Z, Talanov VS, Plascjak PS, Goldman CK, Janik JE, Brechbiel MW, Waldmann TA.

Proc Natl Acad Sci U S A. 2007 May 15;104(20):8444-8. Epub 2007 May 8.

17.

Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience.

Rajagopalan S, Olin J, Deitcher S, Pieczek A, Laird J, Grossman PM, Goldman CK, McEllin K, Kelly R, Chronos N.

Circulation. 2007 Mar 13;115(10):1234-43. Epub 2007 Feb 19.

PMID:
17309918
18.

Ultrasound velocity criteria for carotid in-stent restenosis.

Chi YW, White CJ, Woods TC, Goldman CK.

Catheter Cardiovasc Interv. 2007 Feb 15;69(3):349-54.

PMID:
17171655
19.

The anti-CD25 monoclonal antibody 7G7/B6, armed with the alpha-emitter 211At, provides effective radioimmunotherapy for a murine model of leukemia.

Zhang M, Yao Z, Zhang Z, Garmestani K, Talanov VS, Plascjak PS, Yu S, Kim HS, Goldman CK, Paik CH, Brechbiel MW, Carrasquillo JA, Waldmann TA.

Cancer Res. 2006 Aug 15;66(16):8227-32.

20.

Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy.

Cabrera G, Porvasnik SL, DiCorleto PE, Siemionow M, Goldman CK.

Mol Cancer. 2006 Aug 9;5:32.

21.

Effective therapy for a murine model of human anaplastic large-cell lymphoma with the anti-CD30 monoclonal antibody, HeFi-1, does not require activating Fc receptors.

Zhang M, Yao Z, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Janik J, Brechbiel MW, Waldmann TA.

Blood. 2006 Jul 15;108(2):705-10. Epub 2006 Mar 21.

22.

Surveillance imaging for carotid in-stent restenosis.

Goldman CK, Morshedi-Meibodi A, White CJ, Jaff MR.

Catheter Cardiovasc Interv. 2006 Feb;67(2):302-8.

PMID:
16400679
23.

Preclinical and phase I clinical trial of blockade of IL-15 using Mikbeta1 monoclonal antibody in T cell large granular lymphocyte leukemia.

Morris JC, Janik JE, White JD, Fleisher TA, Brown M, Tsudo M, Goldman CK, Bryant B, Petrus M, Top L, Lee CC, Gao W, Waldmann TA.

Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):401-6. Epub 2005 Dec 30.

24.

Combination therapy for adult T-cell leukemia-xenografted mice: flavopiridol and anti-CD25 monoclonal antibody.

Zhang M, Zhang Z, Goldman CK, Janik J, Waldmann TA.

Blood. 2005 Feb 1;105(3):1231-6. Epub 2004 Sep 21.

25.

Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.

Zhang M, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Brechbiel MW, Carrasquillo JA, Waldmann TA.

Cancer Res. 2004 Aug 15;64(16):5825-9.

26.

IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells.

Vámosi G, Bodnár A, Vereb G, Jenei A, Goldman CK, Langowski J, Tóth K, Mátyus L, Szöllösi J, Waldmann TA, Damjanovich S.

Proc Natl Acad Sci U S A. 2004 Jul 27;101(30):11082-7. Epub 2004 Jul 19.

27.

CT angiogram of aortic dissection and left renal artery stenosis.

Goldman CK, Deitelzweig SB.

Vasc Med. 2004 Feb;9(1):69. No abstract available.

PMID:
15230490
28.

Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.

Askari A, Unzek S, Goldman CK, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS.

J Am Coll Cardiol. 2004 May 19;43(10):1908-14.

29.

Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the alpha-emitting radionuclides (212)Bi or (211)At.

Wesley JN, McGee EC, Garmestani K, Brechbiel MW, Yordanov AT, Wu C, Gansow OA, Eckelman WC, Bacher JD, Flynn M, Goldman CK, MacLin M, Schwartz UP, Jackson-White T, Phillip CM, Decker J, Waldmann TA.

Nucl Med Biol. 2004 Apr;31(3):357-64.

PMID:
15028248
30.

Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.

Zhang Z, Zhang M, Goldman CK, Ravetch JV, Waldmann TA.

Cancer Res. 2003 Oct 1;63(19):6453-7.

31.

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.

Rajagopalan S, Mohler ER 3rd, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH.

Circulation. 2003 Oct 21;108(16):1933-8. Epub 2003 Sep 22.

PMID:
14504183
32.

Protein kinase C mediates induced secretion of vascular endothelial growth factor by human glioma cells.

Tsai JC, Teng LJ, Chen CT, Hong TM, Goldman CK, Gillespie GY.

Biochem Biophys Res Commun. 2003 Oct 3;309(4):952-60.

PMID:
13679066
33.

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS.

Lancet. 2003 Aug 30;362(9385):697-703.

PMID:
12957092
34.

Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts.

Zhang M, Zhang Z, Garmestani K, Schultz J, Axworthy DB, Goldman CK, Brechbiel MW, Carrasquillo JA, Waldmann TA.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1891-5. Epub 2003 Feb 4.

35.

Gene therapy by adenovirus-mediated vascular endothelial growth factor and angiopoietin-1 promotes perfusion of muscle flaps.

Lubiatowski P, Gurunluoglu R, Goldman CK, Skugor B, Carnevale K, Siemionow M.

Plast Reconstr Surg. 2002 Jul;110(1):149-59. Erratum in: Plast Reconstr Surg. 2003 Mar;111(3):1380..

PMID:
12087246
36.

Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha-emitting radionuclide, bismuth 213.

Zhang M, Yao Z, Garmestani K, Axworthy DB, Zhang Z, Mallett RW, Theodore LJ, Goldman CK, Brechbiel MW, Carrasquillo JA, Waldmann TA.

Blood. 2002 Jul 1;100(1):208-16.

37.

Enhancement of muscle flap hemodynamics by angiopoietin-1.

Gurunluoglu R, Lubiatowski P, Goldman CK, Carnevale K, Siemionow M.

Ann Plast Surg. 2002 Apr;48(4):401-9.

PMID:
12068223
38.

Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo.

Byzova TV, Goldman CK, Jankau J, Chen J, Cabrera G, Achen MG, Stacker SA, Carnevale KA, Siemionow M, Deitcher SR, DiCorleto PE.

Blood. 2002 Jun 15;99(12):4434-42.

39.

Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy.

Lubiatowski P, Goldman CK, Gurunluoglu R, Carnevale K, Siemionow M.

Plast Reconstr Surg. 2002 May;109(6):1986-93.

PMID:
11994603
40.

Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer.

Shirakawa K, Shibuya M, Heike Y, Takashima S, Watanabe I, Konishi F, Kasumi F, Goldman CK, Thomas KA, Bett A, Terada M, Wakasugi H.

Int J Cancer. 2002 May 20;99(3):344-51.

41.

Differential effects of IL-2 and IL-15 on expression of IL-2 receptor alpha.

Alileche A, Goldman CK, Waldmann TA.

Biochem Biophys Res Commun. 2001 Aug 3;285(5):1302-8.

PMID:
11478799
42.

Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice.

Perera LP, Goldman CK, Waldmann TA.

Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5146-51. Epub 2001 Apr 10. Erratum in: Proc Natl Acad Sci U S A 2001 Jun 19;98(13):7647.

43.

IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.

Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.

Cancer Res. 2000 Dec 15;60(24):6977-84.

44.

A mechanism for modulation of cellular responses to VEGF: activation of the integrins.

Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, Plow EF.

Mol Cell. 2000 Oct;6(4):851-60.

45.

Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: a phase I/II clinical trial.

Nussenblatt RB, Fortin E, Schiffman R, Rizzo L, Smith J, Van Veldhuisen P, Sran P, Yaffe A, Goldman CK, Waldmann TA, Whitcup SM.

Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7462-6.

46.

Regulation of vascular endothelial growth factor secretion in human meningioma cells.

Tsai JC, Hsiao YY, Teng LJ, Shun CT, Chen CT, Goldman CK, Kao MC.

J Formos Med Assoc. 1999 Feb;98(2):111-7.

PMID:
10083766
47.

IL-15 induces the expression of chemokines and their receptors in T lymphocytes.

Perera LP, Goldman CK, Waldmann TA.

J Immunol. 1999 Mar 1;162(5):2606-12.

48.

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.

Goldman CK, Kendall RL, Cabrera G, Soroceanu L, Heike Y, Gillespie GY, Siegal GP, Mao X, Bett AJ, Huckle WR, Thomas KA, Curiel DT.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8795-800.

49.

Adenovirus-mediated p16 gene transfer prevents drug-induced cell death through G1 arrest in human glioma cells.

Hama S, Heike Y, Naruse I, Takahashi M, Yoshioka H, Arita K, Kurisu K, Goldman CK, Curiel DT, Saijo N.

Int J Cancer. 1998 Jul 3;77(1):47-54.

50.

Endothelial cell vehicles for delivery of cytotoxic genes as a gene therapy approach for carcinoma of the ovary.

Rancourt C, Robertson MW 3rd, Wang M, Goldman CK, Kelly JF, Alvarez RD, Siegal GP, Curiel DT.

Clin Cancer Res. 1998 Feb;4(2):265-70.

Supplemental Content

Loading ...
Support Center